Protocol MS-LAQ-301: A multinational, multicenter, rando

Project: Research project

Project Details

Description

Protocol MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy o
StatusFinished
Effective start/end date8/1/0712/31/11

Funding

  • Teva Neuroscience, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.